Table 1.
Authors | Year | Study Design | Animal | Citicoline Concentration | Citicoline Administration | Outcomes |
---|---|---|---|---|---|---|
Rejdak R et al. [62] | 2002 | case-control | Albino rabbits | 50 mg/kg/twice day | Intraperitoneal injection | Retinal catecholamine levels |
Park CH et al. [65] | 2005 | case-control | Spraue-Dawley rats | 50 mg·kg−1 | Intraperitoneal injection | Thickness of retinal layers and expression of ChAT and TH |
Schuettauf F et al. [64] | 2006 | case-control | Rats | 1 g/kg/daily and 300 mg/kg/daily | Intraperitomeal injection | Retinal ganglion cells density and expression of the antiapoptotic protein Bcl-2 |
Oshitari T et al. [63]. | 2010 | case-control | Cultures from Spraue-Dawley rats | 1 μM | Added to high glucose medium in retinal culture | Apoptosis evaluation by TUNEL assay and Caspase-3 and Caspase-9 activity |
Matteucci A et al. [66]. | 2014 | case-control | Cultures from embryonic rat retina | 10, 100 and 1000 μM | Treated for 96 h and 24 h before glutamate-induced excitotoxic insult and high glucose-promoted neuronal cell damage | Apoptosis evaluation by TUNEL assay and caspase activation |
Summary of experimental studies evaluating the effect of citicoline on retinal ganglion cells survival.